CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
Jiahua Niu(Shanghai First People's Hospital), Xianmin Song(Shanghai Stomatological Hospital), Liping Wan, Jun J. Yang(St. Jude Children's Research Hospital), Tong Yin(Shanghai First People's Hospital), Yu Cai(Shanghai First People's Hospital), Xueying Ding(Shanghai Cell Therapy Research Institute), Kun Zhou(Zhejiang Energy Group (China)), Yuan Lu, Baoxia Dong(Shanghai First People's Hospital), Lin Zhu, Haopeng Wang(Guangxi University), Xiang Fang, Huiying Qiu(Shanghai First People's Hospital), Chongmei Huang(Second Military Medical University), Xuedong Sun
Cited by 25
Related Papers
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse
|Nature Genetics|2013|308
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
|Nature Genetics|2013|293
Expanding and optimizing 3D bioprinting capabilities using complementary network bioinks
|Science Advances|2020|283
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
|The Lancet Oncology|2015|210